Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A primary lymphoma of the skin composed of various numbers of small and large irregular neoplastic follicle center cells. Its morphologic pattern can be nodular, diffuse, or nodular and diffuse. It presents with solitary or grouped plaques and tumors, and it usually involves the scalp, forehead, or trunk. It rarely involves the legs. This type of cutaneous lymphoma tends to remain localized to the skin.
Biomarker and diagnostic research for primary cutaneous follicle center lymphoma has been reported in the published literature.
1 clinical trial registered, 1 recruiting. Interventions under study include drug therapy. Pipeline includes 1 PHASE1. Research is primarily industry-sponsored.
40 publications have been identified in PubMed for primary cutaneous follicle center lymphoma. Research spans Case Report / Case Series (43%), Review / Meta-Analysis (28%), and Basic Science / Preclinical (10%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 17 | 43% |
Data assembled from 4 of 12 sources · Last updated Sep 20, 2026, 8:43 AM UTC
Patient Advocacy Groups (PAGs) provide support, resources, and community for patients and caregivers.
European rare disease database
Genetic and Rare Diseases Info Center
Research summaries |
11 |
28% |
Laboratory research | 4 | 10% |
Other research | 3 | 8% |
Testing and diagnosis research | 3 | 8% |
Clinical study results | 1 | 3% |
Disease patterns and progression | 1 | 3% |
Zhao H (2026). [PMID: 42130620](https://pubmed.ncbi.nlm.nih.gov/42130620/). *Front Oncol*. [Case Report / Case Series]
Scaramuzza L (2026). [PMID: 41935907](https://pubmed.ncbi.nlm.nih.gov/41935907/). *Pharmacol Res*. [Other]
Bernardelli A (2026). [PMID: 41151993](https://pubmed.ncbi.nlm.nih.gov/41151993/). *Eur J Haematol*. [Review / Meta-Analysis]
Attaseth P (2026). [PMID: 41364460](https://pubmed.ncbi.nlm.nih.gov/41364460/). *Clin Nucl Med*. [Case Report / Case Series]
Alhusaini RA (2026). [PMID: 41918664](https://pubmed.ncbi.nlm.nih.gov/41918664/). *Cureus*. [Case Report / Case Series]
Álvarez-Dávalos CM (2026). [PMID: 41728511](https://pubmed.ncbi.nlm.nih.gov/41728511/). *Cureus*. [Case Report / Case Series]
Pesce F (2026). [PMID: 41887960](https://pubmed.ncbi.nlm.nih.gov/41887960/). *Ann Pathol*. [Review / Meta-Analysis]
Manduca S (2026). [PMID: 41813060](https://pubmed.ncbi.nlm.nih.gov/41813060/). *J Cutan Pathol*. [Case Report / Case Series]
Kaufman LC (2026). [PMID: 41633545](https://pubmed.ncbi.nlm.nih.gov/41633545/). *Pediatr Ann*. [Review / Meta-Analysis]
Gao Y (2025). [PMID: 40036483](https://pubmed.ncbi.nlm.nih.gov/40036483/). *Am J Dermatopathol*. [Case Report / Case Series]
AI-curated news mentioning primary cutaneous follicle center lymphoma
Updated Aug 4, 2026
A case study highlights the delayed diagnosis of primary cutaneous histoplasmosis in a patient undergoing tumor necrosis factor alpha inhibitor therapy. This underscores the need for heightened awareness of rare infections in immunocompromised patients.
A 20-year study on primary cutaneous γδ T-cell lymphoma reveals significant clinical heterogeneity, providing insights into patient management and treatment strategies. This research underscores the complexity of this rare lymphoma subtype.
A recent study published in PubMed examines six cases of primary cutaneous follicular helper T-cell lymphoma, contributing valuable insights into its clinicopathological characteristics. This research enhances understanding of this rare lymphoma subtype.